• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腔积液可溶性因子谱预测间皮瘤预后。

Profile of soluble factors in pleural effusions predict prognosis in mesothelioma.

机构信息

National Centre for Asbestos Related Disease, University of Western Australia, Nedlands, WA, Australia.

Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia.

出版信息

Cancer Biomark. 2022;33(1):159-169. doi: 10.3233/CBM-210280.

DOI:10.3233/CBM-210280
PMID:34487023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8925107/
Abstract

BACKGROUND

Pleural mesothelioma is a deadly asbestos induced cancer. Less than 10% of mesothelioma patients survive 5 years post diagnosis. However survival can range from a few months to a number of years. Accurate prediction of survival is important for patients to plan for their remaining life, and for clinicians to determine appropriate therapy. One unusual feature of mesothelioma is that patients frequently present with tumor-associated pleural effusions early in the course of the disease.

OBJECTIVE

To study whether cells and molecules present in pleural effusions provide prognostic information for mesothelioma.

METHODS

We profiled the cellular constituents and concentrations of 40 cytokines, chemokines and cellular factors (collectively "soluble factors") involved in inflammatory and immune signalling pathways in pleural effusion samples from 50 mesothelioma patients.Associations with survival were evaluated by Cox proportional hazards regression methods. Results for the two soluble factors most significantly and independently associated with survival were validated in an independent set of samples (n= 51) using a separate assay system.

RESULTS

Survival analysis revealed that IL8, IL2Ra (CD25) and PF4 were independent determinants of a more negative prognosis in mesothelioma patients, independent of other known prognostic factors. Lipocalin2 and IL4 were associated with better prognosis.

CONCLUSIONS

This study demonstrates that pleural effusions rich in a range of soluble factors are associated with poor prognosis. These findings will enhance our ability to prognosticate outcomes in mesothelioma patients.

摘要

背景

胸膜间皮瘤是一种致命的石棉诱导癌症。不到 10%的间皮瘤患者在诊断后能存活 5 年。然而,存活时间可以从几个月到数年不等。准确预测生存情况对患者规划剩余生命以及临床医生确定适当的治疗方法都很重要。间皮瘤的一个不寻常特征是,患者在疾病早期经常出现与肿瘤相关的胸腔积液。

目的

研究胸腔积液中的细胞和分子是否为间皮瘤提供预后信息。

方法

我们对 50 名间皮瘤患者的胸腔积液样本中的细胞成分和 40 种细胞因子、趋化因子和细胞因子(统称为“可溶性因子”)的浓度进行了分析,这些因子涉及炎症和免疫信号通路。通过 Cox 比例风险回归方法评估与生存的相关性。使用另一种检测系统,在一组独立的样本(n=51)中验证了与生存显著和独立相关的两种可溶性因子的结果。

结果

生存分析表明,IL8、IL2Ra(CD25)和 PF4 是间皮瘤患者预后更差的独立决定因素,与其他已知的预后因素无关。脂联素 2 和 IL4 与较好的预后相关。

结论

本研究表明,富含多种可溶性因子的胸腔积液与预后不良有关。这些发现将增强我们预测间皮瘤患者预后的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9226/8925107/49e25663bf5f/cbm-33-cbm210280-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9226/8925107/fcc5dc4a9fcc/cbm-33-cbm210280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9226/8925107/c7dd7233db50/cbm-33-cbm210280-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9226/8925107/5807fe9ea714/cbm-33-cbm210280-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9226/8925107/49e25663bf5f/cbm-33-cbm210280-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9226/8925107/fcc5dc4a9fcc/cbm-33-cbm210280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9226/8925107/c7dd7233db50/cbm-33-cbm210280-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9226/8925107/5807fe9ea714/cbm-33-cbm210280-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9226/8925107/49e25663bf5f/cbm-33-cbm210280-g004.jpg

相似文献

1
Profile of soluble factors in pleural effusions predict prognosis in mesothelioma.胸腔积液可溶性因子谱预测间皮瘤预后。
Cancer Biomark. 2022;33(1):159-169. doi: 10.3233/CBM-210280.
2
Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma.胸腔积液透明质酸作为胸膜恶性间皮瘤的预后标志物。
Lung Cancer. 2013 Dec;82(3):491-8. doi: 10.1016/j.lungcan.2013.09.016. Epub 2013 Oct 9.
3
Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.胸腔积液的蛋白质组学筛选鉴定出半乳糖凝集素 1 作为一种诊断生物标志物,并突出了几种恶性间皮瘤的预后生物标志物。
Mol Cell Proteomics. 2014 Mar;13(3):701-15. doi: 10.1074/mcp.M113.030775. Epub 2013 Dec 20.
4
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.纤维结合蛋白-3 作为胸腔间皮瘤的血液和渗出液生物标志物。
N Engl J Med. 2012 Oct 11;367(15):1417-27. doi: 10.1056/NEJMoa1115050.
5
Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion.胸腔积液中外泌体亚群的诊断和预后效用。
Biomolecules. 2021 Oct 29;11(11):1606. doi: 10.3390/biom11111606.
6
Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.采用胸腔积液和外周血样本中的生物标志物改善胸膜恶性间皮瘤患者的诊断和预后 - 一份简短报告。
Cell Oncol (Dordr). 2017 Oct;40(5):511-519. doi: 10.1007/s13402-017-0327-7. Epub 2017 Jun 2.
7
Multiplex Soluble Biomarker Analysis from Pleural Effusion.胸腔积液的多重可溶性生物标志物分析。
Biomolecules. 2020 Jul 28;10(8):1113. doi: 10.3390/biom10081113.
8
Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma.胸腔积液中间皮素水平的测定无助于预测恶性胸膜间皮瘤患者的生存。
Anticancer Res. 2019 Sep;39(9):5219-5223. doi: 10.21873/anticanres.13719.
9
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma.纤维结合蛋白-3 和间皮素在恶性间皮瘤中的比较。
Thorax. 2014 Oct;69(10):895-902. doi: 10.1136/thoraxjnl-2014-205205. Epub 2014 Jul 18.
10
Diagnostic and prognostic value of soluble syndecan-1 in pleural malignancies.可溶性syndecan-1在胸膜恶性肿瘤中的诊断和预后价值。
Biomed Res Int. 2014;2014:419853. doi: 10.1155/2014/419853. Epub 2014 Jul 24.

引用本文的文献

1
Research Priorities for Malignant Pleural Organization with Loculation and Failed Drainage.伴有分隔及引流失败的恶性胸腔积液的研究重点
Cells. 2025 Jul 21;14(14):1118. doi: 10.3390/cells14141118.
2
Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor control.低剂量光动力疗法可促进胸部恶性肿瘤中血管E-选择素的表达,改善免疫浸润并控制肿瘤。
J Immunother Cancer. 2025 Jun 10;13(6):e009482. doi: 10.1136/jitc-2024-009482.
3
Multiple Classes of Antigen Contribute to the Antigenic Landscape of Mesothelioma.

本文引用的文献

1
Does size matter? -a population-based analysis of malignant pleural mesothelioma.大小很重要吗?——基于人群的恶性胸膜间皮瘤分析
Transl Lung Cancer Res. 2020 Aug;9(4):1041-1052. doi: 10.21037/tlcr-19-488.
2
Interleukin-6 and interleukin-8 serum levels in prognosis of hormone-dependent breast cancer.白细胞介素-6 和白细胞介素-8 血清水平与激素依赖性乳腺癌的预后。
Cytokine. 2019 Jun;118:93-98. doi: 10.1016/j.cyto.2018.02.019. Epub 2018 Feb 24.
3
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.
多种抗原类别促成了间皮瘤的抗原格局。
Mol Cell Proteomics. 2025 Mar;24(3):100925. doi: 10.1016/j.mcpro.2025.100925. Epub 2025 Feb 5.
4
Interleukin-8/CXCR1 Signaling Contributes to the Progression of Pulmonary Adenocarcinoma Resulting in Malignant Pleural Effusion.白细胞介素-8/CXCR1 信号通路促进肺腺癌进展导致恶性胸腔积液。
Cells. 2024 Jun 3;13(11):968. doi: 10.3390/cells13110968.
5
Pleural Fluid-to-Blood BNP Ratio May Contribute to Prognosis in Malignant Pleural Mesothelioma.胸腔积液与血液中脑钠肽比值可能有助于预测恶性胸膜间皮瘤的预后。
Clin Pract. 2023 Sep 13;13(5):1111-1122. doi: 10.3390/clinpract13050099.
HSP90 抑制改变了化疗驱动的致癌分泌组的重排。
Oncogene. 2018 Mar;37(10):1369-1385. doi: 10.1038/s41388-017-0044-8. Epub 2018 Jan 9.
4
Mesothelioma in Australia: a review.澳大利亚间皮瘤:综述。
Med J Aust. 2017 Nov 20;207(10):449-452. doi: 10.5694/mja17.00397.
5
IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients.白细胞介素-6、白细胞介素-8和肿瘤坏死因子-α水平与乳腺癌患者的疾病分期相关。
Adv Clin Exp Med. 2017 May-Jun;26(3):421-426. doi: 10.17219/acem/62120.
6
An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells.化疗停药后,自分泌炎症正向反馈回路促进耐药乳腺癌细胞的再增殖。
Cell Death Dis. 2017 Jul 13;8(7):e2932. doi: 10.1038/cddis.2017.319.
7
Lipocalin 2: An Emerging Player in Iron Homeostasis and Inflammation.脂质运载蛋白2:铁稳态与炎症中的新兴参与者
Annu Rev Nutr. 2017 Aug 21;37:103-130. doi: 10.1146/annurev-nutr-071816-064559. Epub 2017 Jun 19.
8
Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.衰老相关的白细胞介素-6和白细胞介素-8细胞因子诱导一种自我和交叉强化的衰老/炎症环境,增强MCF-7乳腺癌细胞系的致瘤能力。
Cell Commun Signal. 2017 May 4;15(1):17. doi: 10.1186/s12964-017-0172-3.
9
PF4 Promotes Platelet Production and Lung Cancer Growth.PF4促进血小板生成和肺癌生长。
Cell Rep. 2016 Nov 8;17(7):1764-1772. doi: 10.1016/j.celrep.2016.10.031.
10
Malignant pleural fluid from mesothelioma has potent biological activities.来自间皮瘤的恶性胸腔积液具有强大的生物活性。
Respirology. 2017 Jan;22(1):192-199. doi: 10.1111/resp.12874. Epub 2016 Aug 25.